Status:
UNKNOWN
A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation
Lead Sponsor:
General Hospital of Chinese Armed Police Forces
Conditions:
Hereditary Cerebellar Ataxia.
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Hereditary cerebellar ataxia is a type of autosomal dominant genetic disease, lesions mainly involving the cerebellum, but the spinal cord and cranial nerves may also be some involvement. A total of 2...
Detailed Description
After admission the patients accepted transplantation would receive physical examination, blood and urine tests, electrocardiogram, electrophysiologic study;evaluation of SCA1 symptoms (balance, walki...
Eligibility Criteria
Inclusion
- 18-65 years of age
- Molecularly diagnosed SCA1
Exclusion
- Cognitively impaired individuals
- Schizophrenics
- Patients with severe kidney and liver disease, epilepsy, heart disease, pulmonary disease, cardiac arrhythmia, diabetes insipidus, leukemia and some other central neural disease (such as Parkinson disease, accidence of brain vascular et al)
- Age less than 18 years, age greater than 65 years
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01489267
Start Date
December 1 2011
End Date
July 1 2014
Last Update
June 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yihua An
Beijing, China